|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||
Part 6: Cardiovascular Complications in PD |
University Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, PR China
Correspondence to: A.Y.M. Wang, University Department of Medicine, Queen Mary Hospital, University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong SAR, PR China. aymwang{at}hku.hk
Cardiovascular disease accounts for more than half of all deaths in
end-stage renal disease patients receiving chronic peritoneal dialysis (PD)
treatment. The recent demonstration of the important association between
residual renal clearance (but not PD clearance) and overall and cardiovascular
survival in chronic PD patients has led us to further explore the mechanisms
that can potentially explain the close link between residual renal function
and cardiovascular disease in this population. This John Maher Award Lecture
provides a review of my own work and that of other groups that provides
support for the importance of residual renal function not only in providing
small-solute clearance but also in maintaining the cardiovascular health,
nutrition status, and wellbeing of PD patients. Data are provided to
demonstrate why preservation of residual renal function may be the key to
improving survival and cardiovascular outcomes in PD patients.
KEY WORDS: Residual renal function; cardiovascular disease; nutrition; inflammation; calcification.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |